Spora ApS

Private limited companyCVR 44348454København KActive

Spora ApS is a private limited company, based in København K, active in research and experimental development on natural sciences and engineering, founded in 2023. Equity was negative at the end of 2025 (−DKK 6.6m). The company made a loss in both 2024 and 2025, most recently DKK 10.9m. With 17 employees, the company is about 3 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 3.6m+46.2% vs. 2024
Net profit−DKK 10.9m+6.7% vs. 2024
Equity−DKK 6.6m−257.1% vs. 2024
Employees17latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 11.7m to DKK 10.9m (2024 → 2025).
  • Equity turned negative: −DKK 6.6m (2024 → 2025).

Employees

  • 6 more employees than a year earlier: 17 (07/2026) against 11 (07/2025).

Management and owners, last 24 months

  • New in management: Peter Christiansen (board member, 20/03/2026).
  • Stepped down: Claus Henrik Christiansen (board member, 20/03/2026).
  • New owners registered: Monachus Holding ApS (14/11/2024), Alchemist ApS (08/07/2026) and Romarine ApS (08/07/2026).
  • No longer registered as owner: Monachus Holding ApS (13/11/2024), Alchemist ApS (07/07/2026) and Romarine ApS (07/07/2026).

Registrations, last 24 months

  • 08/07/2026: Share capital changed from 52,191 DKK to 73,067 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
  • 14/11/2024: Share capital changed from 47,619 DKK to 52,191 DKK
  • 29/10/2024: Moved to Refshalevej 153, st, 1432 København K

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2024–2025 · amounts in DKK thousand

Equity and net profit

−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2mDKK 4m20242025
EquityNet profit
Financial figures for Spora ApS
20242025Change
Revenuenot statednot stated–
Gross profit−6,755−3,631+46.2%
Operating profit (EBIT)−11,667−10,966+6%
Profit before tax−11,734−11,088+5.5%
Net profit−11,660−10,876+6.7%
Total assets6,0364,322−28.4%
Equity4,230−6,646−257.1%
Liabilities1,80610,968+507.3%
Cash and cash equivalents3,26351−98.4%
Average number of employees612+100%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 7m−DKK 6m−DKK 5m−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1m20242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Negative equity

    Equity was −DKK 6.6m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 2 years in a row

    Net result has been negative in 2024–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

2 financial years
Annual reports for Spora ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202514/07/2026The companyPDF not statedXBRL
202404/10/2023 – 31/12/202430/06/2025The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101214161811/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 3.6mNo. 367 of 421
Better than 13% of the companies in the industry
Equity−DKK 6.6mNo. 390 of 431
Better than 10% of the companies in the industry
Number of employees17No. 129 of 431
Better than 70% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,438of 69,742
Better than 0%
No. 69,370of 69,964
Better than 1%
Same industry and fewer than 20 employees329 companies in the comparison
No. 287of 323
Better than 11%
No. 299of 329
Better than 9%
Companies that are founded within the last five years16,662 companies in the comparison
No. 16,525of 16,614
Better than 1%
No. 16,542of 16,661
Better than 1%
All companies of type ApS66,508 companies in the comparison
No. 66,126of 66,379
Better than 0%
No. 65,910of 66,505
Better than 1%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Spora ApS−DKK 3.6m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Spora ApS−DKK 10.9m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Spora ApS−DKK 6.6m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Spora ApS17
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Spora ApS

Management

4 active registrations

Executive management

Executive management at Spora ApS
NameRoleAppointed
Mette JohnsenDirector14/11/2023

Board of directors

Board of directors at Spora ApS
NameRoleAppointed
Rasmus Munk Møller ThomassenChair of the board14/11/2023
Jørgen HauglundBoard member29/04/2024
Peter ChristiansenBoard member20/03/2026
Founders
Monachus Holding ApS
Former management (4)
Former management at Spora ApS
NameRoleAppointedResigned
Rasmus Munk Møller ThomassenDirector04/10/202314/11/2023
Mikkel Steen AndersenBoard member14/11/202329/04/2024
Mette JohnsenBoard member14/11/202329/04/2024
Claus Henrik ChristiansenBoard member29/04/202420/03/2026

Signing rule: Selskabet tegnes af bestyrelsesformanden, af en direktør i forening med bestyrelsesformanden, af en direktør i forening med den samlede bestyrelse eller af den samlede bestyrelse.

Address and production units

1 active production units

Refshalevej 153
1432 København K

København Municipality · Postcode 1432

Production units
Production unitAddressEmployeesP number
Spora ApSRefshalevej 153, st, 1432 København K161029710577

Purpose

Selskabets formål er forskning, udvikling og salg indenfor fødevarer.

The purpose is quoted from the register in Danish.

Changes year by year

34 registered events
20268 changesaccounts 1 · capital 1 · ownership 4 · management 2
  • Annual report for 2025 published
  • Share capital changed from 52,191 DKK to 73,067 DKK
  • Romarine ApS registered as owner (25%)
  • Alchemist ApS registered as owner (20%)
  • Romarine ApS is no longer registered as owner
  • Alchemist ApS is no longer registered as owner
  • Peter Christiansen appointed board member
  • Claus Henrik Christiansen stepped down as board member
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20248 changescapital 1 · ownership 2 · address 1 · management 4
  • Share capital changed from 47,619 DKK to 52,191 DKK
  • Monachus Holding ApS registered as owner (33.33%)
  • Monachus Holding ApS is no longer registered as owner
  • Moved to Refshalevej 153, st, 1432 København K
  • Claus Henrik Christiansen appointed board member
  • Jørgen Hauglund appointed board member
  • Mikkel Steen Andersen stepped down as board member
  • Mette Johnsen stepped down as board member
202316 changescapital 1 · ownership 7 · management 6 · industry 1 · founded 1
  • Share capital changed from 40,000 DKK to 47,619 DKK
  • Romarine ApS registered as owner (15%)
  • Alchemist ApS registered as owner (25%)
  • Alchemist ApS is no longer registered as owner
  • Monachus Holding ApS registered as owner (50%)
  • Alchemist ApS registered as owner (33.33%)
  • Mette Johnsen appointed director
  • Rasmus Munk Møller Thomassen appointed chair of the board
  • Mikkel Steen Andersen appointed board member
  • Mette Johnsen appointed board member
  • Rasmus Munk Møller Thomassen stepped down as director
  • Monachus Holding ApS is no longer registered as owner
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
  • Registered as Spora ApS
  • Rasmus Munk Møller Thomassen appointed director
  • Monachus Holding ApS registered as owner (100%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction